Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School
Boehringer Ingelheim
Express Scripts

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,763,476

« Back to Dashboard

Which drugs does patent 5,763,476 protect, and when does it expire?

Patent 5,763,476 protects SAPHRIS and is included in one NDA. There has been one Paragraph IV challenge on Saphris.

Protection for SAPHRIS has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 5,763,476

Title: Sublingual or buccal pharmaceutical composition
Abstract:The invention relates to a sublingual or buccal pharmaceutical composition comprising trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino-[4 ,5-c]pyrrole or a pharmaceutically acceptable salt thereof, and pharmaceutically acceptable auxiliaries suitable for use in sublingual or buccal compositions, and the use thereof for the manufacture of a sublingual or buccal pharmaceutical composition for the treatment of mental disorders, such as psychosis and schizophrenia.
Inventor(s): Delbressine; Leonardus Petrus Carla (Nijmegen, NL), Wieringa; Johannes Hubertus (Heesch, NL)
Assignee: Akzo Noble N.V. (Arnhem, NL)
Application Number:08/693,064
Patent Claim Types:
see list of patent claims
Composition; Compound; Use; Process; Formulation;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Forest Labs Llc
asenapine maleate
TABLET;SUBLINGUAL022117-003Mar 12, 2015RXYesNo► Subscribe► SubscribeY
Forest Labs Llc
asenapine maleate
TABLET;SUBLINGUAL022117-001Aug 13, 2009RXYesNo► Subscribe► SubscribeY
Forest Labs Llc
asenapine maleate
TABLET;SUBLINGUAL022117-002Aug 13, 2009RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 5,763,476

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
94200521Mar 02, 1994
PCT Information
PCT FiledMarch 01, 1995PCT Application Number:PCT/EP95/00765
PCT Publication Date:September 08, 1995PCT Publication Number: WO95/23600

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
US Army
Harvard Business School
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus